Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
L-RD (Luzerne - Recherche Développement) is a French biotechnology company founded in 2005 by the alfalfa dehydration industry to develop innovative applications for alfalfa (lucerne). Headquartered in Châlons-en-Champagne, the company specializes in plant fractionation and the extraction of high-value nutritional components from alfalfa leaves. Its flagship product, Luzixeen, is a concentrated alfalfa protein extract that has received European Commission authorization as a Novel Food ingredient for dietary supplements. L-RD focuses on providing sustainable, plant-based protein alternatives and nutrient-rich extracts for the global nutraceutical and food industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on L-RD.